Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...

A recent study published in the journal Drug and Alcohol Dependence suggests that poor sleep in people with alcohol use ...

A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...